In Johannesburg, a patient with moderate depression covered by a medical aid scheme sees a psychologist every Tuesday at 10 a.m. for a full hour. Two thousand kilometres north, in rural Kenya, a woman with the same diagnosis waits three months for her first appointment at a public clinic, then receives a 15-minute check-in once a month. Both carry the same label—major depressive disorder—but the treatment calendars could not be more different. The frequency of mental health care, determined less by clinical need than by who pays, is emerging as one of the most stubborn fault lines in global health equity.

Weekly vs. Monthly: The Structural Divide in Talk Therapy

Private insurance plans in middle-income countries typically authorise weekly 50-minute psychotherapy sessions for conditions such as depression and anxiety disorders. In South Africa, the Council for Medical Schemes reports that many medical aid schemes cover 12 to 20 sessions per year, often with the option to renew after a psychiatrist's referral. Patients can schedule weekly appointments and exhaust their benefit within three to five months, then reapply.

Public programmes, by contrast, operate on a different logic. In Kenya's public mental health system, outpatient visits average roughly 15 minutes, and follow-up intervals stretch to four weeks or longer. The World Health Organization's Mental Health Gap Action Programme (mhGAP) trains non-specialist health workers to deliver brief interventions, but the protocol does not mandate a minimum session frequency. In practice, monthly slots are rationed for crisis cases, leaving patients with mild-to-moderate depression waiting in long queues.

Clinicians report that patients stabilise faster with weekly contact. A 2020 meta-analysis in JAMA Psychiatry found that weekly cognitive behavioural therapy for depression produced a 50% remission rate at 12 weeks, compared with roughly 25% for biweekly sessions. Yet public health systems, facing a shortage of specialists, often cannot afford the workforce to deliver weekly care. The gap widens for severe anxiety disorders, where exposure therapy benefits from frequent, structured sessions.

South Africa's dual system illustrates the divide. A patient with private insurance can access a clinical psychologist who charges around US$ 60 to US$ 80 per session, with the insurer covering 70–80% after a deductible. In the public sector, a single psychiatrist at a large tertiary hospital may see 50 to 80 patients per day, leaving no room for weekly talk therapy. The result: two entirely different care trajectories for the same diagnosis.

How Public Programme Design Creates Waiting Lists and Rationing

Public mental health services in low- and middle-income countries are chronically underfunded. According to the WHO's 2023 Mental Health Atlas, the median number of mental health workers per 100,000 population in Africa is 1.6, compared with 63 in Europe. This scarcity forces health ministries to ration by frequency. In Uganda's national referral hospital, a single psychiatrist may see over 200 outpatients per day, with each visit lasting less than 10 minutes. Follow-ups are scheduled at four- to six-week intervals, and only patients deemed at high risk—those with suicidal ideation or psychosis—are seen more often.

The design of public programmes often prioritises acute care over maintenance. In Kenya, the outpatient mental health protocol at district hospitals specifies a 15-minute consultation for new patients and 10 minutes for follow-ups. There is no standard for how frequently follow-ups should occur; the decision is left to the clinician's discretion, which is constrained by patient volume. A 2022 study in BMC Psychiatry found that 60% of patients with depression attending public clinics in Nairobi had gaps of more than six weeks between visits, and one-third dropped out entirely.

Waiting lists compound the problem. In Zambia, the only psychiatric hospital in the country has a waiting time for a first appointment that can stretch to six months. During that period, patients often receive no structured psychological support, only medication refills from a general practitioner. The mhGAP programme attempts to bridge this gap by training nurses and clinical officers to deliver brief counselling, but the intervention is limited to four to six sessions, spaced monthly. As one Ugandan psychiatrist told me, “We are not treating depression; we are managing crises.”

The rationing logic is understandable from a budget perspective. A monthly session costs less than a weekly one, and the limited workforce can serve more patients. But the clinical evidence suggests that low-frequency care may be less effective for moderate-to-severe depression. A 2019 Cochrane review found that psychotherapy delivered weekly produced significantly better outcomes than less frequent schedules, and that dropout rates rose sharply when sessions were spaced more than two weeks apart. The tension between population coverage and individual efficacy remains unresolved in most public systems.

Private Insurance Favours Chronic, Not Acute, Mental Health Care

Private insurance policies in many countries are designed to manage chronic conditions, not acute episodes. For mental health, this means authorising ongoing therapy for depression and anxiety but often excluding or limiting coverage for substance-use disorders, which are viewed as behavioural or self-inflicted. In South Africa, the Medical Schemes Act requires coverage for 15 days of hospitalisation per year for substance abuse, but outpatient therapy is typically capped at 12 sessions. Weekly therapy for alcohol dependence is rarely covered; patients must pay out-of-pocket.

Even for covered conditions, private insurers impose hurdles. Weekly therapy is authorised only after a psychiatrist's referral, and pre-certification is required every six to twelve sessions. Patients must demonstrate medical necessity—often through a diagnosis of major depressive disorder or generalised anxiety disorder—and insurers may deny additional sessions if clinical improvement is not documented. A 2021 study in the South African Journal of Psychiatry found that 40% of private-sector patients with depression had their therapy sessions reduced or denied after the initial block.

The cost of weekly therapy in the private sector is substantial. In Kenya, a session with a private psychologist costs between US$ 60 and US$ 150 per hour, depending on the city and the therapist's qualifications. In Nigeria, the range is similar, and only about 5% of the population has private health insurance that covers outpatient mental health. For the wealthy, this means access to cognitive behavioural therapy, eye movement desensitisation and reprocessing (EMDR) for trauma, or specialised dialectical behaviour therapy. For the rest, the public system offers monthly group therapy or medication alone.

Private insurance also favours individual therapy over group or family therapy, which are often more cost-effective. Insurers argue that individual sessions are more evidence-based for conditions like depression, but the evidence for group cognitive behavioural therapy is nearly as strong. The real driver may be profit: individual sessions are easier to bill and monitor. The result is a system that perpetuates a two-tiered approach, where the frequency of care is determined by the depth of the patient's wallet.

The Same Diagnosis, Two Different Recovery Curves

Consider two hypothetical patients with moderate depression. Patient A, covered by private insurance in Nairobi, begins weekly cognitive behavioural therapy. After 12 weeks, roughly 50% of patients in this scenario achieve remission, according to trial data. Patient B, attending a public clinic in the same city, receives a monthly 15-minute check-in and a prescription for a selective serotonin reuptake inhibitor. After six months, studies suggest that 20–30% of such patients show clinically significant improvement, and many drop out before the third visit.

The recovery curves diverge early. Weekly therapy allows for the development of a therapeutic alliance, homework compliance, and real-time adjustment of coping strategies. Monthly sessions, by contrast, often devolve into medication management and brief symptom checks. A 2018 study in The Lancet Psychiatry comparing weekly versus monthly psychotherapy for depression found that the weekly group had a 1.7 times higher odds of remission at 12 weeks, and the effect persisted at six months. The monthly group showed slower improvement and higher relapse rates.

Dropout is a major issue in low-frequency care. When sessions are spaced too far apart, patients lose momentum, forget skills, or feel that treatment is not working. A 2022 systematic review in Global Mental Health reported that dropout rates in public mental health programmes in sub-Saharan Africa ranged from 30% to 60%, with longer intervals between sessions predicting higher dropout. Private patients, who have invested financially and logistically, are more likely to persist.

Private patients also have better access to combination therapy—medication plus psychotherapy—which is the gold standard for moderate depression. In public clinics, medication is often the only option, and psychotherapy is reserved for those who fail first-line treatment. The gap in recovery trajectories is not just a matter of frequency; it reflects a broader disparity in the comprehensiveness of care. As one Nairobi-based psychologist put it, “The public system gives you a pill and a prayer. The private system gives you a plan.”

Policy Levers: What Could Close the Frequency Gap?

Several strategies have been proposed to narrow the divide between weekly and monthly care. Task-sharing, already used in HIV and maternal health, trains community health workers to deliver brief, structured psychotherapy in weekly sessions. In Zimbabwe, the Friendship Bench programme—where lay health workers provide problem-solving therapy on wooden benches in primary care clinics—has shown remission rates comparable to individual therapy, at a fraction of the cost. The model is being adapted in Kenya and Malawi, but scaling requires sustained funding and supervision.

Digital platforms offer another avenue. In Kenya, the app MyDawa provides low-cost text-based counselling for depression and anxiety, with weekly check-ins for a monthly subscription of roughly US$ 10. Similar services, such as the South African platform The Counselling Hub, offer weekly video sessions for US$ 30 per session—still out of reach for many, but cheaper than private practice. A 2023 randomised trial in The Lancet Digital Health found that app-based weekly cognitive behavioural therapy was non-inferior to face-to-face weekly therapy for mild depression, suggesting that technology could reduce the frequency gap without requiring more specialists.

Brazil's Centros de Atenção Psicossocial (CAPS) model provides a more ambitious example. These community-based centres offer daily psychosocial care for people with severe mental illness, including group therapy, occupational activities, and individual sessions. The model is publicly funded and serves as an alternative to hospitalisation. For depression and anxiety, CAPS typically offers weekly group therapy, with individual sessions as needed. The cost is high—around US$ 50 per user per month—but the outcomes are promising. A 2020 evaluation found that CAPS users had lower hospitalisation rates and higher quality of life than those in standard outpatient care.

Insurance mandates could also shift the landscape. In Chile, a 2019 reform required private insurers to cover at least 20 psychotherapy sessions per year for depression and anxiety, with no prior authorisation. The policy increased utilisation by 30% in the first year, though critics note that deductibles remain high. South Africa's National Health Insurance, still in development, proposes to cover a minimum of 12 sessions per year for all mental health conditions, but implementation has been delayed. Conditional cash transfers tied to therapy attendance—used in Mexico's Prospera programme—have shown modest success in keeping patients engaged, but the evidence base is thin.

None of these levers is a silver bullet. Task-sharing requires training and supervision; digital platforms require internet access and literacy; insurance mandates require political will and fiscal space. The frequency gap is ultimately a symptom of underinvestment. Until mental health receives a larger share of health budgets—currently less than 2% of government health spending in most African countries—the divide between weekly and monthly care will persist. But incremental changes, piloted and scaled, can begin to close it.

Trade-offs and Counter-Arguments: Is Weekly Always Better?

Not all mental health professionals agree that weekly therapy is universally superior. Some argue that for mild depression or anxiety, monthly sessions combined with self-help materials can be as effective as weekly therapy, especially when the patient is motivated. A 2021 study in Behaviour Research and Therapy found that patients with mild symptoms who received monthly guided self-help had outcomes similar to those receiving weekly face-to-face therapy at 12 weeks, though the effect was not sustained at six months. This suggests that for a subset of patients, lower frequency may be acceptable, freeing up resources for those with more severe conditions.

Moreover, public health officials point out that increasing session frequency without addressing underlying social determinants—such as poverty, unemployment, and housing instability—may have limited impact. A patient who cannot afford transport to a weekly appointment, or who must prioritise work over therapy, may benefit more from a flexible schedule that includes phone check-ins or community-based support. In India, the Atmiyata programme trained community volunteers to provide monthly peer support and crisis referral, and a 2019 evaluation found significant reductions in depression symptoms, even with infrequent contact. The programme's success highlights that quality of interaction may matter as much as quantity.

There is also the risk that mandating weekly therapy in public systems could lead to even longer waiting lists. If every patient with depression is entitled to weekly sessions, the workforce shortage would become even more acute, potentially pushing those in crisis to the back of the line. A 2020 modelling study in PLOS Medicine estimated that shifting from monthly to weekly care for all depression patients in Kenya would require a 400% increase in the mental health workforce, which is unrealistic in the short term. Thus, a targeted approach—weekly for severe cases, monthly or biweekly for mild-to-moderate—may be a more feasible compromise.

Finally, some clinicians caution that the evidence favouring weekly therapy comes largely from high-income countries, where patients have stable housing, transport, and social support. In low-resource settings, the benefits of weekly therapy may be diluted by high dropout rates due to competing demands. A 2022 qualitative study in Global Health Action found that patients in rural Ghana valued the social aspect of group therapy over individual frequency, and that monthly group sessions with peer support were more acceptable than weekly individual appointments. Cultural preferences and logistical realities must shape any effort to close the frequency gap.

This article is for informational purposes only and does not constitute medical or professional advice. Individuals seeking mental health care should consult a qualified provider.